Pembrolizumab Plus Axitinib Versus Sunitinib as First-line Treatment of Advanced Renal Cell Carcinoma: 43-month Follow-up of the Phase 3 KEYNOTE-426 Study-Reference-Cited by-同舟云学术

Pembrolizumab Plus Axitinib Versus Sunitinib as First-line Treatment of Advanced Renal Cell Carcinoma: 43-month Follow-up of the Phase 3 KEYNOTE-426 Study

Published:2023-11 Issue:5 Volume:84 Page:449-454
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Plimack Elizabeth R.,Powles Thomas,Stus Viktor,Gafanov Rustem,Nosov Dmitry,Waddell Tom,Alekseev Boris,Pouliot Frédéric,Melichar Bohuslav,Soulières Denis,Borchiellini Delphine,McDermott Raymond S.,Vynnychenko Ihor,Chang Yen-Hwa,Tamada Satoshi,Atkins Michael B.,Li Chenxiang,Perini Rodolfo,Molife L. Rhoda,Bedke Jens,Rini Brian I.

Funder

Merck Sharp and Dohme

Publisher

Elsevier BV

Subject

Urology

Reference11 articles.

1. Recent eUpdate to the ESMO clinical practice guidelines on renal cell carcinoma on cabozantinib and nivolumab for first-line clear cell renal cancer: renal cell carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Powles;Ann Oncol,2021

2. Updated European Association of Urology guidelines on renal cell carcinoma: nivolumab plus cabozantinib joins immune checkpoint inhibition combination therapies for treatment-naïve metastatic clear-cell renal cell carcinoma;Bedke;Eur Urol,2021

3. Kidney cancer, version 3.2022, NCCN clinical practice guidelines in oncology;Motzer;J Natl Compr Canc Netw,2022

4. Pembrolizumab plus axitinib versus sunitinib for advanced renal-cell carcinoma;Rini;N Engl J Med,2019

5. Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trial;Powles;Lancet Oncol,2020

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Randomized phase 2 dose comparison LITESPARK-013 study of belzutifan in patients with advanced clear cell renal cell carcinoma;Annals of Oncology;2024-09

2. Report of a case of renal collecting duct carcinoma with literature review;Discover Medicine;2024-08-29

3. The treatment of metastatic renal cell carcinoma;Deutsches Ärzteblatt international;2024-08-23

4. Perceptions and Expectations: A Study on Prognostic Perception and Quality of Life in Patients With Metastatic Renal and Bladder Cancer;JCO Global Oncology;2024-08

5. Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 8-year follow-up results of efficacy and safety from the phase III CheckMate 214 trial;Annals of Oncology;2024-08